Trump Eases Psychedelic Drug Rules
President Trump has signed an executive order significantly easing federal restrictions on psychedelic drug research, aiming to accelerate studies into their potential therapeutic benefits for mental health challenges. This groundbreaking move also permits patient access to some investigational psychedelic drugs, signaling a new era for mental health treatment exploration.